Effects of Cardiopulmonary Rehabilitation Promotion Mode Intervention Combined with Oxygen Therapy on Cardiopulmonary Function and Blood Gas Analysis Indexes of COPD Patients with Cor Pulmonale

Overview

Journal J Healthc Eng

Specialty Biomedical Engineering

Date 2022 Apr 5

PMID 35378941

Authors

Xiangmei Xie

Huihong Chen

Jie Fan

Qin Min

Donghua Fan

Affiliations

Soon will be listed here.

Abstract

Chronic obstructive pulmonary disease is a common respiratory disease. This paper observes the effects of cardiopulmonary rehabilitation promotion mode intervention combined with oxygen therapy on cardiopulmonary function and blood gas analysis indexes in patients with chronic obstructive pulmonary disease (COPD) complicated with cor pulmonale. A total of 136 COPD patients with cor pulmonale admitted to our hospital from July 2018 to October 2020 were selected as the research objects and divided into two groups by a simple random method. 136 patients are given oxygen therapy while the traditional group and cardiopulmonary rehabilitation group are given traditional mode and cardiopulmonary rehabilitation promotion mode intervention. Cardiopulmonary rehabilitation promotion mode intervention combined with oxygen therapy can improve the cardiopulmonary function of COPD patients with cor pulmonale, regulate the expression of related serum factors, improve self-care ability, and reduce the number of hospitalizations.

Citing Articles

Retracted: Effects of Cardiopulmonary Rehabilitation Promotion Mode Intervention Combined with Oxygen Therapy on Cardiopulmonary Function and Blood Gas Analysis Indexes of COPD Patients with Cor Pulmonale.

Healthcare Engineering J J Healthc Eng. 2023; 2023:9810235.

PMID: 37829434 PMC: 10567168. DOI: 10.1155/2023/9810235.

References

Nichols S, McGregor G, Breckon J, Ingle L . Current Insights into Exercise-based Cardiac Rehabilitation in Patients with Coronary Heart Disease and Chronic Heart Failure. Int J Sports Med. 2020; 42(1):19-26. DOI: 10.1055/a-1198-5573. View

Barnes P, Shapiro S, Pauwels R . Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003; 22(4):672-88. DOI: 10.1183/09031936.03.00040703. View

Fan S, Eiser C, Ho M . Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol. 2010; 8(7):559-64.e1-10. DOI: 10.1016/j.cgh.2010.03.008. View

Liu Z, Lang L, Li L, Zhao Y, Shi L . Evolutionary game analysis on the recycling strategy of household medical device enterprises under government dynamic rewards and punishments. Math Biosci Eng. 2021; 18(5):6434-6451. DOI: 10.3934/mbe.2021320. View

Kee K, Wang J, Lee C, Chen C, Changchien C, Hu T . Validation of clinical AJCC/UICC TNM staging system for hepatocellular carcinoma: analysis of 5,613 cases from a medical center in southern Taiwan. Int J Cancer. 2007; 120(12):2650-5. DOI: 10.1002/ijc.22616. View

Kocks J, Blom C, Kasteleyn M, Oosterom W, Kollen B, van der Molen T . Feasibility and applicability of the paper and electronic COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ) in primary care: a clinimetric study. NPJ Prim Care Respir Med. 2017; 27(1):20. PMC: 5434785. DOI: 10.1038/s41533-017-0023-0. View

Yasui H, Inui N, Karayama M, Mori K, Hozumi H, Suzuki Y . Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease. Respir Med. 2019; 146:76-80. DOI: 10.1016/j.rmed.2018.11.020. View

Yang M, Xu Y, Chen H, Xu Z, Luo F . Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Inflammopharmacology. 2019; 28(2):451-462. DOI: 10.1007/s10787-019-00659-5. View

Helgeson S, Taylor B, Lim K, Lee A, Niven A, Patel N . Characterizing Particulate Generation During Cardiopulmonary Rehabilitation Classes With Patients Wearing Procedural Masks. Chest. 2021; 160(2):633-641. DOI: 10.1016/j.chest.2021.02.045. View

10.

Ren H, Jiang Y, Wang S, Wang Y, Wang J . Efficacy and safety of Shufeng Jiedu Capsule in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021; 100(1):e24198. PMC: 7793378. DOI: 10.1097/MD.0000000000024198. View

11.

Oganesyan A, Hoffner-Heinike A, Barker A, Frank B, Ivy D, Hunter K . Abnormal pulmonary flow is associated with impaired right ventricular coupling in patients with COPD. Int J Cardiovasc Imaging. 2021; 37(10):3039-3048. DOI: 10.1007/s10554-021-02285-1. View

12.

Jiang G, Li Q, Lv Y . Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2018; 14:73-80. PMC: 6304246. DOI: 10.2147/COPD.S186872. View

13.

Widmer R, Senecal C, Allison T, Lopez-Jimenez F, Lerman L, Lerman A . Dose-Response Effect of a Digital Health Intervention During Cardiac Rehabilitation: Subanalysis of Randomized Controlled Trial. J Med Internet Res. 2020; 22(2):e13055. PMC: 7066512. DOI: 10.2196/13055. View

14.

Grouse L . Selective polypharmacy for chronic obstructive pulmonary disease. J Thorac Dis. 2015; 7(3):E16-8. PMC: 4387440. DOI: 10.3978/j.issn.2072-1439.2015.01.40. View